Sign up
Pharma Capital

Digipath Inc. plans to expand into California, other parts of the US this year

Digipath Inc. (OTCQB:DIGP) CEO Todd Denkin says the independent laboratory testing and media firm is planning on expanding operations into California and other parts of the country this year.

Denkin says the company is also exploring opportunities internationally, especially cannabis testing and research and development globally.


View full DIGP profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.